TrialThe lancet. Gastroenterology & hepatology2016

Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial.

John G Williams et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.